Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix r&d expenses
Research and development expenses are spending on new products and technology.
Agentix's R&D Expenses for the twelve months ending Jun 30, 2026 was $41.71K, down 81.5% year over year. For fiscal 2026 it was $125.08K, down 30.9% from the year before. The highest annual figure on record is $365.13K in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $125.08K | -30.9% |
| FY2025 | Mar 31, 2025 | $180.99K | +3.3% |
| FY2024 | Mar 31, 2024 | $175.27K | -52.0% |
| FY2021 | Aug 31, 2021 | $365.13K | +9789.8% |
| FY2016 | Aug 31, 2016 | $3.69K | -87.0% |
| FY2015 | Aug 31, 2015 | $28.33K | -54.1% |
| FY2014 | Aug 31, 2014 | $61.75K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $16.64K | -83.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $0 | -100.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0 | -100.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $25.08K | +111.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $100.00K | +80.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $90.35K | +96.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $23.29K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $11.85K | -79.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $55.50K | -64.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $46.02K | -59.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$87.30K | -251.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $58.37K | -67.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $158.18K | +921.3% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $113.91K | +8294.4% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $57.50K | – |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $178.33K | +10427.3% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $15.49K | +1139.0% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $1.36K | +81.4% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $0 | -100.0% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | $1.69K | +1594.0% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $1.25K | -93.5% |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | $748 | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | $5.51K | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | $100 | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | $19.30K | – |
See a number that looks wrong?